late 1
relapses 1
following 1
highdose 1
autologous 1
stem 1
cell 1
transplantation 1
hdasct 1
hodgkins 1
lymphoma 1
hl 1
abvd 1
therapeutic 1
era 1
phase 1
study 1
cladribine 1
cytarabine 1
arac 1
granulocyte 1
colony 1
stimulating 1
factor 1
gcsf 1
clag 1
regimen 1
simultaneous 1
escalating 1
doses 1
imatinib 1
mesylate 1
gleevec 1
relapsedrefractory 1
aml 1
